Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare hematological (Blood) disorder.Regulatory approval for the Phase II trial in PNH subjects was granted based on the safety profile of healthy ...

Symptom improvement with novel therapies and better patient-reported outcomes, as well as breakthrough hemolysis control, are among the paroxysmal nocturnal hemoglobinuria highlights from ASH 2024.

Physicians presented the case of a man with paroxysmal nocturnal hemoglobinuria and concurrent Plasmodium falciparum infection.

A panel of experts discusses the nuances of treating paroxysmal nocturnal hemoglobinuria in older patients, focusing on comorbidities and complications.

Paroxysmal nocturnal hemoglobinuria is a rare chronic disease that can be challenging to manage. Learn what you can do to cope with PNH.

Piasky approved for the treatment of adult and pediatric patients 13 years of age and older with paroxysmal nocturnal hemoglobinuria weighing at least 40kg.

For example, a patient with PNH who presents with bone marrow failure is a candidate for a bone marrow transplant or immunotherapy. For patients presenting more typically—with significant, continuous, ...

As, for example, bone marrow can be severely impacted in patients with PNH, developing a more comprehensive understanding of the disease can help guide and inform earlier interventions to combat ...

Building upon their partnership announced last year, digital health leader Dawn Health and global pharmaceutical company Novartis are proud to announce the launch of Ekiva PNH, an innovative digital ...

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare condition that causes low blood cell levels and sometimes bone marrow failure. It sometimes develops in people who have another blood disorder ...